ToxSci Advance Access originally published online on February 19, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Toxicological Sciences 79, 56-63 (2004)
Toxicological Sciences vol. 79 no. 1 © Society of Toxicology; all rights reserved.
Inorganic Cadmium- and Arsenite-Induced Malignant Transformation of Human Bladder Urothelial Cells




,1
Departments of Pathology and * Surgery, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, North Dakota 58202
Received December 9, 2003; accepted January 23, 2004
Arsenic and cadmium (Cd+2) are human carcinogens, and epidemiological studies have implicated both pollutants in the development of urinary bladder cancer. Despite this epidemiological base, it is unknown if either Cd+2 or arsenite (As+3) can directly cause the malignant transformation of human urothelial cells. The goal of this study was to determine if Cd+2 and/or As+3 are able to cause the malignant transformation of human urothelial cells. The strategy employed was to expose the nontumorigenic urothelial cell line UROtsa to long-term in vitro exposure to Cd+2 and As+3, with the endpoint being the ability of the cells to form colonies in soft agar and tumors when heterotransplanted into nude mice. It was demonstrated that a long-term exposure to either 1 M Cd+2 or 1 M As+3 resulted in the selection of cells that were able to form colonies in soft agar and tumors when heterotransplanted into nude mice. The histology of the tumor heterotransplants produced by UROtsa cells malignantly transformed by Cd+2 had epithelial features consistent with those of a classic transitional-cell carcinoma of the bladder. The histology of the tumor heterotransplants produced by cells malignantly transformed by As+3 was unique in that the cells displayed a prominent squamoid differentiation.
Key Words: cadmium; arsenite; arsenic; bladder cancer; UROtsa; cell culture.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
T. J. Jensen, P. Novak, K. E. Eblin, A. J. Gandolfi, and B. W. Futscher Epigenetic remodeling during arsenical-induced malignant transformation Carcinogenesis, August 1, 2008; 29(8): 1500 - 1508. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Eblin, T. G. Bredfeldt, S. Buffington, and A. J. Gandolfi Mitogenic Signal Transduction Caused by Monomethylarsonous Acid in Human Bladder Cells: Role in Arsenic-Induced Carcinogenesis Toxicol. Sci., February 1, 2007; 95(2): 321 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Somji, X. D. Zhou, S. H. Garrett, M. A. Sens, and D. A. Sens Urothelial Cells Malignantly Transformed by Exposure to Cadmium (Cd+2) and Arsenite (As+3) Have Increased Resistance to Cd+2 and As+3-Induced Cell Death Toxicol. Sci., December 1, 2006; 94(2): 293 - 301. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. D. Zhou, M. A. Sens, S. H. Garrett, S. Somji, S. Park, V. Gurel, and D. A. Sens Enhanced Expression of Metallothionein Isoform 3 Protein in Tumor Heterotransplants Derived from As+3- and Cd+2-Transformed Human Urothelial Cells Toxicol. Sci., October 1, 2006; 93(2): 322 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. D. Zhou, D. A. Sens, M. A. Sens, V. B. R. K. Namburi, R. K. Singh, S. H. Garrett, and S. Somji Metallothionein-1 and -2 Expression in Cadmium- or Arsenic-Derived Human Malignant Urothelial Cells and Tumor Heterotransplants and as a Prognostic Indicator in Human Bladder Cancer Toxicol. Sci., June 1, 2006; 91(2): 467 - 475. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Garrett, S. Park, M. A. Sens, S. Somji, R. K. Singh, V. B. R. K. Namburi, and D. A. Sens Expression of Metallothoinein Isoform 3 Is Restricted at the Post-Transcriptional Level in Human Bladder Epithelial Cells Toxicol. Sci., September 1, 2005; 87(1): 66 - 74. [Abstract] [Full Text] [PDF] |
||||

